NewAmsterdam Pharma Company N.V. (NAMS) Fundamentals
NewAmsterdam Pharma Company N.V. (NAMS) fundamentals on the US markets. Fundamentals360 brings together a fair value estimate from a set of valuation models, valuation multiples, dividend history and yield, income statement, balance sheet and cash flow, a capital score, and a peer comparison, so you can judge whether NAMS looks cheap or expensive versus its own history and its peers.
See the full NAMS fundamentals, fair value, and dividends on Portfolio360.